Brian Lian, President & CEO at Viking Therapeutics, Inc. (VKTX), sold 35,000 shares at $23.95 ($838K) on 2024-01-30, disclosed to the SEC on 2024-01-30.
Scheduled sale ($838k) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| VKTX | SELL | 2025-10-28 | $2.7M | — | Filing → |
| VKTX | SELL | 2025-07-03 | $1.5M | — | Filing → |
| VKTX | SELL | 2025-01-06 | $15.8M | — | Filing → |